RE:RE:RE:Clear signal to management
Great posts Aureus / Stag.... you guys are absolutely right on the mark.
Management's fumbles, overoptimism and lack of execution with regard to monetizing the IP are absolutely culpable here. its been frustrating as heck. You can even layer in the poor partnership decisions that have been made over the years, and the tendency to drag everything cash related out to the 11th hour..... If it were only a 6 month or a 12 month problem you could almost forgive it, but this has been a 10 year problem.
THATS why the company has been heavilly shorted, thats why the institutional community has largely blackballed this company.....and THAT is why its trading so low relative to its peers.
Here's the rub.... its exactly all that well earned doubt and negativity that creates the opportunity....IF you do your homework and make the decision that it can and IS being turned around.
There are handful of very smart , experienced posters and readers here that spend an inordinate amount of time communicating directly with all levels of Management , Scientists, The Board of directors and the largest shareholders. This is done both formally and informally as a process to provide feedback, advice and even to leverage relationships that could positively affect the company.
I can tell you definitively that starting almost exactly a year ago, when all of the shite really started hitting the fan here, many smart influential investors became much more engaged and focussed. Now I am not by any means saying that everything is all roses all of a sudden, but i can tell you that between its largest investors and its Board of Directors, that Prometic has some very smart and accomplished people. I have witnessed first hand the efforts being undertaken to address the heart of the problems that have been so painful. Not the least of which is the establishment of the Board Committee who's specific independent mandate is to formulate and execute a strategy of Monteziation of the IP. This also includes the mandate to improve Investment Relations and to formally engagee at least one prominent Investment Bank to help execute the various large undertakings and opportunities at hand.
As everyone here knows.... there are many that hang all of this on PL..... and there is no doubt he has his considerable shortcomings.....and has made plenty of mistakes BUT... and its a BIG BUT...... you cant go there without acknowledging the almost uncanny string of clinical successes and the resulting underlying IP build that has occurred......and almost all of this has been done without giving up any meaningful future.
The fact that Prometic controls 95% of its formidable IP has not been given enough consideration here. CC Abbot and Sanjay the Panmure Gordon Analyst brought that to light when discussing the relative value of Fibrogen and Galapagos. Ask yourself this... what does this company look like if in Q1 it announced a major licensing deal along the lines of what those companies have done ??? and how quickly does that change the relative valuation question ? Throw in the fact that 4050 and analogues have shown considerable multi organ Anti Fibrotic efficacy... and you start to see the real opportunity.... and that's not even considering the Pg franchise Those torturing over what amounts to a relatively small funding gap will be silenced and hurting.
I believe that the board has more independence than ever, I also really like Bruce Pritchard's conservative, hands-on pragmatic approach...
HISTORY will ultimately be the judge, but I believe wholeheartedly that all the negative sentiment and the horrilble price action of the last year can and will reverse in very short order with a couple of what are finally now imminent catalysts. ..... and all this teeth gnashing and worrying will be gone for good